You are here

Article info

Article menu
Original research
General practitioners’ risk literacy and real-world prescribing of potentially hazardous drugs: a cross-sectional study

Authors

  • Odette Wegwarth Heisenberg Chair for Medical Risk Literacy & Evidence-Based Decisions, Charité Universitätsmedizin Berlin Campus Charite Mitte, Berlin, Germany Adpative Rationality, Max-Planck-Institute for Human Development, Berlin, Germany PubMed articlesGoogle scholar articles
  • Tammy C Hoffmann Faculty of Health Sciences and Medicine, Institute for Evidence-Based Healthcare, Bond University, Gold Coast, Queensland, Australia PubMed articlesGoogle scholar articles
  • Ben Goldacre Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK PubMed articlesGoogle scholar articles
  • Claudia Spies Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité—Universitätsmedizin Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Helge A Giese Heisenberg Chair for Medical Risk Literacy & Evidence-Based Decisions, Charité Universitätsmedizin Berlin Campus Charite Mitte, Berlin, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Odette Wegwarth; odette.wegwarth{at}charite.de
View Full Text

Citation

Wegwarth O, Hoffmann TC, Goldacre B, et al
General practitioners’ risk literacy and real-world prescribing of potentially hazardous drugs: a cross-sectional study
BMJ Quality & Safety 2024;33:634-641.

Publication history

  • Received November 30, 2023
  • Accepted April 8, 2024
  • First published April 17, 2024.
Online issue publication 
September 19, 2024

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.